Deep learning–guided engineering of SpuFz1 and rational miniaturization of ωRNA enables efficient genome editing
Open Access
- 18 June 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Advancing the performance of programmable genome editing nucleases remains a key challenge in expanding their research and therapeutic applications. Here, we introduce a scalable deep learning–guided protein engineering framework for improving nuclease activity without requiring experimental training data. As a demonstration, we apply this strategy to SpuFz1, a compact Fanzor nuclease of eukaryotic origin, identifying and validating beneficial mutations that produces a multi-mutant variant with an 11.6-fold increase in editing efficiency. In parallel, we use comparative sequence analysis to design and experimentally validate a 75-nt ultrashort ωRNA scaffold, reducing guide RNA length by 79% while maintaining activity. Integration of these optimized components yields enFanzor, a compact genome editing system that achieves editing efficiencies up to 81.9% in mammalian cells, with strong editing performance in both human hematopoietic stem and progenitor cells (HSPCs) and mouse embryos. The outperforming variant developed through this strategy also supports robust CBE and ABE activity. Notably, the shortened ωRNA not only improves nuclease editing specificity but also leads to a substantial increase in base editing efficiency. Together, this work demonstrates the power of combining AI-guided protein optimization with rational RNA design, and establishes a generalizable strategy for engineering next-generation genome editing tools.Keywords
This publication has 45 references indexed in Scilit:
- Fanzors, a family of eukaryotic RNA‐guided DNA endonucleasesFEBS Letters, 2025
- Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryosMolecular Cell, 2024
- CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editingScience China Life Sciences, 2024
- An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysisCell, 2023
- Engineering of efficiency-enhanced Cas9 and base editors with improved gene therapy efficaciesMolecular Therapy, 2022
- Immunity to CRISPR Cas9 and Cas12a therapeuticsWIREs Mechanisms of Disease, 2017
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- In vivo genome editing using Staphylococcus aureus Cas9Nature, 2015
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013